Company profile for Artelo Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Artelo Biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. Our programs have the potential to dramatically improve patient care in major markets. We expect to deliver on the promise of new med...
Artelo Biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. Our programs have the potential to dramatically improve patient care in major markets. We expect to deliver on the promise of new medicines to treat a wide range of diseases and conditions for patients in need of better outcomes. By doing so, we will create value for patients, physicians, and our investors.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
888 Prospect Street, Suite 210 La Jolla, CA. 92037
Telephone
Telephone
(760) 943-1689
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/12/3186180/0/en/Artelo-Biosciences-Provides-Business-Update-and-Reports-Third-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
12 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180341/0/en/Artelo-Biosciences-Announces-Publication-of-Peer-Reviewed-Article-on-Role-of-Fatty-Acid-Binding-Proteins-in-Cancer.html

GLOBENEWSWIRE
04 Nov 2025
Artelo Bio Appoints Mark Spring As CFO
Artelo Bio Appoints Mark Spring As CFO

27 Oct 2025

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2025/10/27/3174506/0/en/Artelo-Biosciences-Names-Veteran-Life-Sciences-Executive-Mark-Spring-CPA-as-Chief-Financial-Officer.html

GLOBENEWSWIRE
27 Oct 2025

https://www.globenewswire.com/news-release/2025/10/15/3167179/0/en/Artelo-Biosciences-Announces-Expanded-Clinical-Data-to-be-Presented-on-both-ART26-12-and-ART27-13-at-the-8th-Annual-Cannabinoid-Endocannabinoid-Drug-Development-Summit.html

GLOBENEWSWIRE
15 Oct 2025
Artelo Bio Closes $2M Public Offering
Artelo Bio Closes $2M Public Offering

01 Oct 2025

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2025/10/01/3159920/0/en/Artelo-Biosciences-Announces-Closing-of-2-0-Million-Public-Offering.html

GLOBENEWSWIRE
01 Oct 2025
Artelo Bio Sets $2M Public Offering Price
Artelo Bio Sets $2M Public Offering Price

30 Sep 2025

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2025/09/30/3158608/0/en/Artelo-Biosciences-Announces-Pricing-of-2-0-Million-Public-Offering.html

GLOBENEWSWIRE
30 Sep 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty